News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,833 Results
Type
Article (86782)
Company Profile (704)
Press Release (764346)
Multimedia
Podcasts (141)
Webinars (19)
Section
Business (232786)
Career Advice (4132)
Deals (39752)
Drug Delivery (129)
Drug Development (91075)
Employer Resources (198)
FDA (18168)
Job Trends (17359)
News (396752)
Policy (39806)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (105)
Alliances (56970)
ALS (115)
Alzheimer's disease (1547)
Antibody-drug conjugate (ADC) (186)
Approvals (18116)
Artificial intelligence (384)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (127)
Biotechnology (481)
Bladder cancer (96)
Brain cancer (39)
Breast cancer (381)
Cancer (2989)
Cardiovascular disease (240)
Career advice (3540)
Career pathing (34)
CAR-T (201)
CDC (39)
Cell therapy (557)
Cervical cancer (24)
Clinical research (74150)
Collaboration (1072)
Company closure (3)
Compensation (662)
Complete response letters (30)
COVID-19 (2897)
CRISPR (64)
C-suite (325)
Cystic fibrosis (117)
Data (2942)
Decentralized trials (2)
Denatured (49)
Depression (67)
Diabetes (372)
Diagnostics (6969)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (172)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (129)
Earnings (97435)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131360)
Executive appointments (901)
FDA (19821)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (985)
Gene editing (142)
Generative AI (37)
Gene therapy (424)
GLP-1 (921)
Government (5245)
Grass and pollen (6)
Guidances (180)
Healthcare (20915)
Huntington's disease (31)
IgA nephropathy (42)
Immunology and inflammation (174)
Immuno-oncology (9)
Indications (40)
Infectious disease (3079)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17896)
IRA (55)
Job creations (5192)
Job search strategy (2863)
Kidney cancer (15)
Labor market (55)
Layoffs (584)
Leadership (26)
Legal (10131)
Liver cancer (84)
Lung cancer (422)
Lymphoma (206)
Machine learning (9)
Management (65)
Manufacturing (419)
MASH (93)
Medical device (14706)
Medtech (14711)
Mergers & acquisitions (22545)
Metabolic disorders (939)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2270)
NextGen: Class of 2025 (7687)
Non-profit (5089)
Now hiring (48)
Obesity (483)
Opinion (288)
Ovarian cancer (100)
Pain (115)
Pancreatic cancer (120)
Parkinson's disease (197)
Partnered (25)
Patents (306)
Patient recruitment (155)
Peanut (55)
People (65647)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22892)
Phase II (32192)
Phase III (24242)
Pipeline (1625)
Policy (233)
Postmarket research (3552)
Preclinical (10335)
Press Release (72)
Prostate cancer (145)
Psychedelics (41)
Radiopharmaceuticals (277)
Rare diseases (503)
Real estate (7399)
Recruiting (76)
Regulatory (27062)
Reports (61)
Research institute (2664)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (165)
Series B (109)
Service/supplier (30)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (63)
The Weekly (90)
Vaccines (893)
Venture capital (54)
Weight loss (327)
Women's health (48)
Worklife (20)
Date
Today (130)
Last 7 days (594)
Last 30 days (2784)
Last 365 days (34168)
2025 (17372)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50473)
Australia (8873)
California (7602)
Canada (2334)
China (705)
Colorado (330)
Connecticut (342)
Delaware (200)
Europe (115793)
Florida (1122)
Georgia (259)
Hawaii (2)
Idaho (66)
Illinois (726)
India (32)
Indiana (382)
Iowa (18)
Japan (226)
Kansas (115)
Kentucky (32)
Louisiana (18)
Maine (73)
Maryland (1086)
Massachusetts (5818)
Michigan (273)
Minnesota (476)
Mississippi (3)
Missouri (98)
Montana (32)
Nebraska (26)
Nevada (80)
New Hampshire (73)
New Jersey (2127)
New Mexico (31)
New York (2143)
North Carolina (1223)
North Dakota (10)
Northern California (3271)
Ohio (245)
Oklahoma (16)
Oregon (48)
Pennsylvania (1630)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (35)
South Dakota (1)
Southern California (2789)
Tennessee (127)
Texas (1154)
United States (28762)
Utah (226)
Virginia (208)
Washington D.C. (80)
Washington State (673)
West Virginia (4)
Wisconsin (83)
There are 851,833 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
June 26, 2025
·
5 min read
Press Releases
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
June 26, 2025
·
10 min read
Press Releases
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
June 26, 2025
·
4 min read
Cardiovascular disease
Novartis Makes Potential $750M+ Bet Per Cardiovascular Disease Target in Another Flagship Pact
Flagship Pioneering’s ProFound Therapeutics will use its proprietary technology to mine the expanded proteome for novel cardiovascular therapeutics. Novartis has promised to pay up to $750 million per target, though it has not specified how many targets it will go after.
June 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
June 26, 2025
·
6 min read
Press Releases
Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin Diseases
June 26, 2025
·
6 min read
Press Releases
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer
June 26, 2025
·
4 min read
Press Releases
Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting
June 26, 2025
·
7 min read
Press Releases
Annovis to Attend the AAIC 2025 with Four Poster Presentations
June 26, 2025
·
2 min read
Press Releases
CIRCA Scientific Announces Successful Completion of Limited Market Release for CrossWise™ RF Transseptal Access System and Expands Compatibility to Additional Sheaths
June 26, 2025
·
3 min read
1 of 85,184
Next
